Circulating adhesion molecule levels in childhood asthma

Figen Doğu1, Aydan Ikincioğullari, Yonca Eğin

  • 1Department of pediatric Immunology-Allergy, Ankara University, School of Medicine, Ankara, Turkey. esin.figen@veezy.com

Indian Pediatrics
|December 6, 2002
PubMed

Insights

In acute asthma, circulating E-selectin levels were significantly higher. Serum E-selectin and ICAM-1 show promise as biomarkers for monitoring childhood asthma activity.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Biomarker Discovery

Background:

  • Asthma is a chronic inflammatory airway disease.
  • Endothelial adhesion molecules like E-selectin, ICAM-1, and VCAM-1 play a role in inflammation.
  • Circulating forms of these molecules may reflect disease activity.

Purpose of the Study:

  • To compare levels of soluble E-selectin, ICAM-1, and VCAM-1 in children with acute asthma, stable asthma (atopic and nonatopic), and healthy controls.
  • To evaluate the potential of these molecules as biomarkers for childhood asthma.

Main Methods:

  • Quantification of serum E-selectin, ICAM-1, and VCAM-1 levels using immunoassays.
  • Comparison of biomarker levels across four groups: acute asthma, stable atopic asthma, stable nonatopic asthma, and healthy children.
  • Statistical analysis to determine significant differences between groups.

Main Results:

  • Significantly elevated serum E-selectin levels were observed in patients with acute asthma compared to other groups.
  • A minor, non-significant increase in soluble ICAM-1 was noted, potentially influenced by inhaled corticosteroid use.
  • No significant differences were found for VCAM-1 levels across the groups.

Conclusions:

  • Serum E-selectin is a potential biomarker for assessing disease activity in acute childhood asthma.
  • Serum ICAM-1 may also serve as a useful marker, though its levels can be affected by treatment.
  • These soluble adhesion molecules warrant further investigation for monitoring pediatric asthma.